VS Health Corporation (NYSE: CVS) reported first-quarter 2021 earnings results today. Total revenues increased 3.5% to $69.1 billion compared to the same period last year, driven by growth across all segments. Net income attributable to CVS was $2.22 billion, or $1.68 per share, compared to $2.01 billion, or $1.53 per share, in the year-ago period. […]
VS Health Corporation (NYSE: CVS) reported first-quarter 2021 earnings results today. Total revenues increased 3.5% to $69.1 billion compared to the same period last year, driven by growth across all segments. Net income attributable to CVS was $2.22 billion, or $1.68 per share, compared to $2.01 billion, or $1.53 per share, in the year-ago period. […]
VS Health Corporation (NYSE: CVS) reported first-quarter 2021 earnings results today.
Total revenues increased 3.5% to $69.1 billion compared to the same period last year, driven by growth across all segments.
Net income attributable to CVS was $2.22 billion, or $1.68 per share, compared to $2.01 billion, or $1.53 per share, in the year-ago period. Adjusted EPS amounted to $2.04.
